Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 5098-5109

  Peng, Yufeng ^a   Trevejo, Jose ^b   Zhou, Junliang ^a   Marino, Michael W ^d   Crystal, Ronald G ^c   Falck Pedersen, Erik ^b   Elkon, Keith B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b Hearst Research Foundation   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EXPRESSION VECTOR; GENE TECHNOLOGY; GENE THERAPY; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

EID: 0032992987     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.5098-5109.1999     Document Type: Article

References (39)

1. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305-1308.
2. Baldwin, A. S., Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
3. Banner, D., A. D'Arcy, W. Janes, R. Gentz, H. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kDa TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431-445.
4. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
5. Bullard, D. C., P. D. King, M. J. Hicks, B. Dupont, A. L. Beaudet, and K. B. Elkon. 1997. ICAM-1 deficiency protects MRL/MpJ-Faslpr mice from early lethality. J. Immunol. 159:2058-2067.
6. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on human dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
7. Chirmule, N., J. V. Hughes, G.-P. Gao, S. E. Raper, and J. M. Wilson. 1998. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 72:6138-6145.
8. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
9. Drappa, J., N. Brot, and K. B. Elkon. 1993. The Fas protein is expressed at high levels on double positive thymocytes and activated mature T cells in normal but not MRL/lpr mice. Proc. Natl. Acad. Sci. USA 90:10340-10344.
10. Elkon, K. B., C. C. Liu, J. G. Gall, J. Trevejo, M. W. Marino, K. A. Abrahamsen, L. J. Old, R. G. Crystal, X. Song, J. L. Zhou, and E. Falck-Pedersen. 1997. TNF-α plays a central role in immune mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA 94:9814-9819.
11. Elkon, K. B., and A. Marshak-Rothstein. 1996. B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. Curr. Opin. Immunol. 8:852-859.
12. Feldmann, M., F. M. Brennan, and R. N. Maini. 1995. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397-440.
13. + T-cell immunity to murine rotavirus in the absence of perform, Fas, and gamma interferon. J. Virol. 71:479-486.
14. Galle, P. R., W. J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/ Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
15. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
16. Hiramatsu, N., N. Hayashi, K. Katayama, K. Mochizuki, Y. Kawanishi, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359.
17. Ilan, Y., G. Droguett, N. R. Chowdhury, Y. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhury, and M. S. Horwitz. 1997. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc. Natl. Acad. Sci. USA 94:2587-2592.
18. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256-3262.
19. Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity dependent APO-1 (Fas/ CD95) associated proteins from a death inducing signaling complex (DISC) with the receptor. EMBO. J. 14:5579-5588.
20. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3:409-413.
21. Lieber, A., C. Y. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. A. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:8798-8807.
22. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
23. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809.
24. Onel, K., D. Ashany, J. Nikolic-Zugic, E. Lacy, and K. B. Elkon. 1995. Expression and function of the murine CD95 Fas/APO-1 receptor in relation to B cell tolerance. Eur. J. Immunol. 25:2940-2947.
25. Orlinick, J. R., K. B. Elkon, and M. V. Chao. 1997. Separate domains of the human Fas ligand dictate self-association and receptor binding. J. Biol. Chem. 272:32221-32229.
26. Orlinick, J. R., A. K. Vaishnaw, and K. B. Elkon. Structure and function of Fas/Fas ligand. Int. Rev. Immunol., in press.
27. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
28. Sallusto, F., and A. Lanzavecchia. 1994. Efficient preparation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
29. Shisler, J., C. Yang, B. Walter, C. F. Ware, and L. R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:8299-8306.
30. Suzuki, M., R. Singh, M. A. Moore, W. R. Song, and R. G. Crystal. 1998. Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes. Hum. Gene. Ther. 29:1223-1231.
31. Tollefson, A. E., T. W. Hermiston, D. L. Lichtenstein, C. F. Colle, R. A. Tripp, T. Dimitrov, K. Toth, C. E. Wells, P. C. Doherty, and W. S. M. Wold. 1998. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392:726-730.
32. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
33. Wallach, D., M. Boldin, E. Varfolomeev, R. Beyaert, P. Vandenabeele, and W. Fiers. 1997. Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 410:96-106.
34. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
35. Wilson, C., and M. A. Kay. 1995. Immunomodulation to enhance gene therapy. Nat. Med. 1:887-893.
36. Wold, W. S. M., T. W. Hermiston, and A. E. Tollefson. 1994. Adenovirus proteins that subvert host defenses. Trends Microbiol. 2:437-443.
37. Worgall, S., P. Leopold, G. Wolff, B. Ferris, N. van Roijen, and R. G. Crystal. 1997. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered by the epithelial surface of the respiratory tract. Human. Gene Ther. 8:1687-1696.
38. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
39. Zajac, A. J., D. G. Quinn, P. L. Cohen, and J. A. Frelinger. 1996. Fas dependent CD4+ cytotoxic T cell-mediated pathogenesis during virus infection. Proc. NaIl. Acad. Sci. USA 93:14730-14735.